VEVArx sells sermorelin, glutathione and NAD+ only in three-month blocks and prints the prepaid total beside its own per-month equivalent. PT-141 is the exception it also sells by the month.
By Nora Castellan, Standards EditorUpdated September 2026
Quarters, priced two ways
Each product card names a three-month plan, gives the total, and states the per-month equivalent the seller has already calculated.
Both numbers are recorded here: the total as a prepaid figure, the equivalent as a monthly rate. Neither is invented, because both are printed.
That makes VEVArx comparable to monthly sellers without anyone having to guess how long a course lasts.
One product escapes the quarter
PT-141 is sold on a flexible monthly plan as well as a three-month one, with the monthly figure stated per month and the three-month total stated with its own equivalent.
So a reader who wants to try it before committing can, on that one product and no other.
Sermorelin, glutathione and NAD+ are three-month commitments with no monthly option published.
What each plan includes
The cards list what the money buys — a licensed provider evaluation, the treatment plan if prescribed, delivery and ongoing support — rather than only what it costs.
The site states plainly that compounded medications are not approved by the FDA and have not been reviewed for safety, effectiveness or quality.
It also notes that its charts are illustrative and its product images may not match what arrives, which is more candour than the category usually offers.
The gaps
No operating company appears on any page read.
No list of served states is published and no dispensing pharmacy is named.
No certificate of analysis is reachable, and nothing in the live federal warning-letter table attaches to the brand.
Who it's for
Buyers comfortable prepaying a quarter for a lower monthly equivalent.
Readers who want the per-month figure printed rather than implied.
Shoppers who want PT-141 available month to month.
Anyone who wants a plan's inclusions listed beside its price.
Who should look elsewhere
Readers who want sermorelin, glutathione or NAD+ a month at a time.
Buyers who need a named company or pharmacy.
Anyone who needs a published state list.
Shoppers who want published testing.
Strengths
Prints the prepaid total and the per-month equivalent on the same card
Offers PT-141 month to month as well as on a three-month plan
States plainly that compounded medications are not approved by the FDA
Lists what each plan includes rather than only what it costs
Trade-offs
Sells sermorelin, glutathione and NAD+ only in three-month blocks
Publishes no operating company on any page read
Publishes no state list and names no dispensing pharmacy
No certificate of analysis is reachable
How we verified this
Read each product page and recorded the prepaid total and the seller's own per-month equivalent as separate rows.
Recorded PT-141's monthly plan separately from its three-month plan, because the seller publishes both.
Recorded what each plan states it includes rather than assuming the figure is medication only.
Searched the site for an operating company, a state list and a named pharmacy and recorded that none appears.
Screened the brand against the live federal warning-letter table with a positive and a nonsense control in the same run.
A provider to compare VEVArx against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.